Mollusan Med spojrzenie medyczne

Clove essential oil (clove bud oil) [ eugenol, isoeugenol, isomeric sesquiterpene hydrocarbons]

antiviral effect
antioxidative effect
antibacterial effect – among others on Streptococcus mutans, Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, Escherichia coli.
antifungal effect – effective in combating dermatophytes, yeast-like fungi (Candida albicans), moulds (Aspergillus)

Coconut oil [fatty acids: lauric (49%), myristic (18%), palmitic, caprylic, oleic and other]

Australian sandalwood oil

Vitamin E (tocopheryl acetate)

Mollusan Med – the influence of the medical product components supporting the body in the fight against molluscum contagiosum

Antiviral and anti-inflammatory effect on viral infection

Antibacterial and antifungal effect for prevention of additional infection

Regenerative supporting effect

Moisturising supporting effect

Emollient supporting properties of the preparation

Lubricating support effect of the preparation

Antioxidative

Antipruritic*

Skuteczność działania	Bezpieczeństwo stosowania	Inne
Pleiotropic effect (multi-directional): Antibacterial Antiviral Antimycotic Anti-inflammatory Moisturising Lubricating Regenerative Antipruritic Antioxidative	It does not cause local complications (scars, discolorations) unlike physical methods (cryotherapy, laser therapy, curettage, electrocoagulation)	Pleasant smell (clove oil, sandalwood oil, coconut oil)
Fast performance – lesions begin to subside after 4 weeks of systematic use	Does not irritate the skin – patient-friendly/good compliance	Easy dosage – 2-3 times a day
	Safe – may be used already at the age of 4 years
	Safe – based on natural, not synthetic, ingredients

Intended user

Patient with molluscum contagiosum:
Children aged 3 -10 years, often suffering also from Atopic Dermatitis [AD]

Adults:

STIs – sexually-transmitted infections
patients with immunosuppression – e.g. HIV infection
patients using immunosuppressive agents, e.g. methotrexate, cyclosporin (in autoimmune diseases, after organ transplantations)
Sources:

1.W.H.C. Burgdorf, G. Plewig, H.H. Wolff, M. Landthaler, Dermatologia Braun-Falco, Tom 1: Wydawnictwo Czelej sp. Z o.o. 2017

* practically absent in MCV infections